Alrex

Company
Bausch & Lomb, Pharmos

Approval Status
Approved March 1998

Treatment for
seasonal allergic conjunctivitis

Areas
Eye Health / Ophthalmology

Alrex is indicated for the treatment of seasonal allergic conjunctivitis, an inflammation of the eye usually caused by pollens. Seasonal allergic conjunctivitis produces itching, tearing, redness, and swelling in the membrane that covers the inside of the eyelid and the white part of the eye.

Alrex Drug Information

The Alrex drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top